Akutsu M, Dikic I, Bremm A (2016) Ubiquitin chain diversity at a glance. J Cell Sci 129(5):875–880
Article CAS PubMed Google Scholar
Berlingieri MT, Pallante P, Sboner A et al (2007) UbcH10 is overexpressed in malignant breast carcinomas. Eur J Cancer 43(18):2729–2735
Article CAS PubMed Google Scholar
Blanco-Prieto S, Barcia-Castro L, Paez DLCM et al (2017) Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis. BMC Cancer 17(1):823
Article PubMed PubMed Central Google Scholar
Cao JZ, Nie G, Hu H et al (2022) UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation. J Gastrointest Oncol 13(3):1444–1453
Article PubMed PubMed Central Google Scholar
Chiang AJ, Li CJ, Tsui KH et al (2020) UBE2C drives human cervical cancer progression and is positively modulated by mTOR. Biomolecules 11(1):37
Article PubMed PubMed Central Google Scholar
Chiranjeevi P, Spurthi KM, Rani NS et al (2014) Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer. Tumour Biol 35(2):1351–1356
Article CAS PubMed Google Scholar
Cockram PE, Kist M, Prakash S et al (2021) Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ 28(2):591–605
Article CAS PubMed PubMed Central Google Scholar
Dastsooz H, Cereda M, Donna D et al (2019) A comprehensive bioinformatics analysis of UBE2C in cancers. Int J Mol Sci 20(9):2228
Article CAS PubMed PubMed Central Google Scholar
Guo L, Ding Z, Huang N et al (2017) Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death. Cell Cycle 16(18):1705–1718
Article CAS PubMed PubMed Central Google Scholar
Guo J, Wu Y, Du J et al (2018) Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression. Oncogenesis 7(6):49
Article PubMed PubMed Central Google Scholar
Hao Z, Zhang H, Cowell J (2012) Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker. Tumour Biol 33(3):723–730
Article CAS PubMed Google Scholar
Hou H, Zhang G, Wang H et al (2014) High matrix metalloproteinase-9 expression induces angiogenesis and basement membrane degradation in stroke-prone spontaneously hypertensive rats after cerebral infarction. Neural Regen Res 9(11):1154–1162
Article CAS PubMed PubMed Central Google Scholar
Hsu CC, Huang SF, Wang JS et al (2016) Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion. BMC Cancer 16(1):800
Article PubMed PubMed Central Google Scholar
Huang H (2018) Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances. Sensors 18(10):3249
Article PubMed PubMed Central Google Scholar
Ivan P, Fabiana N, Annalidia D et al (2020) UbcH10 a major actor in cancerogenesis and a potential tool for diagnosis and therapy. Int J Mol Sci 21(6):2041
Jin Z, Zhao X, Cui L et al (2020) UBE2C promotes the progression of head and neck squamous cell carcinoma. Biochem Biophys Res Commun 523(2):389–397
Article CAS PubMed Google Scholar
Joseph C, Alsaleem M, Orah N et al (2020) Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival. Breast Cancer Res Treat 182(2):267–282
Article CAS PubMed PubMed Central Google Scholar
Kadara H, Lacroix L, Behrens C et al (2009) Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system. Cancer Prev Res 2(8):702
Lenglet S, Montecucco F, Mach F et al (2014) Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb Haemost 112(2):363–378
Article CAS PubMed Google Scholar
Lin L, Yu Y, Xiumei Z (2019) MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway. Biomed Pharmacother 117:1090
Liu Y, Zhao R, Chi S et al (2020) UBE2C is upregulated by estrogen and promotes epithelial-mesenchymal transition via p53 in endometrial cancer. Mol Cancer Res 18(2):204–215
Article CAS PubMed Google Scholar
Mehner C, Hockla A, Miller E et al (2014) Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget 5(9):2736–2749
Article PubMed PubMed Central Google Scholar
Ni M, Liu X, Wu J et al (2018) Identification of candidate biomarkers correlated with the pathogenesis and prognosis of non-small cell lung cancer via integrated bioinformatics analysis. Front Genet 9:469
Article CAS PubMed PubMed Central Google Scholar
Nicolau-Neto P, Palumbo A, De Martino M et al (2018) UBE2C is a transcriptional target of the cell cycle regulator FOXM1. Genes 9(4):188
Article PubMed PubMed Central Google Scholar
Niland S, Riscanevo AX, Eble JA (2021) Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int J Mol Sci 23(1):146
Article PubMed PubMed Central Google Scholar
Oliver AL (2022) Lung cancer: epidemiology and screening. Surg Clin North Am 102(3):335–344
Paupert J, Mansat-De MV, Demur C et al (2008) Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features. Cell Cycle 7(8):1047–1053
Article CAS PubMed Google Scholar
Shen M, Ren X (2017) Highlights on immune checkpoint inhibitors in non-small cell lung cancer[Z]. London, England: SAGE Publications 39:1393394651
Shi X, Shao X, Zhang Y et al (2020) Tumor location and survival outcomes in lung adenosquamous carcinoma: a propensity score matched analysis. Med Sci Monit 26:e922138
Article PubMed PubMed Central Google Scholar
Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463–516
Article CAS PubMed PubMed Central Google Scholar
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Wang R, Song Y, Liu X et al (2017) UBE2C induces EMT through Wnt/betacatenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A. Int J Oncol 50(4):1116–1126
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Huang F, Liu M et al (2021) UBE2C mRNA expression controlled by miR-300 and HuR determines its oncogenic role in gastric cancer. Biochem Biophys Res Commun 534:597–603
Comments (0)